The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

In April 2025, Kamau Therapeutics announced a study is a first-in-human, single-arm, open-label Phase I/II study of nula-cel ...

I care deeply because this chronic disease is mine. It lives inside me. It’s radically changed my life and the life of my ...

Our discovery has found a possible treatment that could specifically target and help patients with this disease"(Boston)—The global burden of chronic ...

Renova Health's AI and machine learning technology provides TNF with the capability to sift through several subject records.

The FDA has granted a speedy review of Eli Lilly ... to reduce the risk of renal failure and cardiovascular death in people with chronic kidney disease (CKD). The new indication could unlock ...

Mineralys plans to provide additional data from the pivotal Phase 3 Launch-HTN at an upcoming medical conference and in a peer-reviewed publication. Additionally, the ongoing Transform-HTN open-label ...

The outbreak linked to romaine lettuce killed one person and sickened at least 88 more, including a 9-year-old boy who nearly ...

Since the FDA approval, Bayer has also reported ... "The worrying reality is that chronic kidney disease in type 2 diabetes is the leading cause of end-stage kidney disease, which ultimately ...